cancer pain
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1.Pathologically confirmed malignant tumor with pain caused by tumor invasion/progression or tumor treatment; 2.Aged 18 to 80 years with an expected survival of =3 months; 3.Moderate-to-severe pain defined as a Visual Analog Scale (VAS) score =4; 4.Conscious capable of understanding and communicating as required for the study and willing to sign the informed consent form
Exclusion criteria
Exclusion criteria: 1 Pain related to oncological emergencies such as fractures visceral obstruction or perforation 2 Severe organ dysfunction or uncontrolled infections 3 Pregnant or lactating women 4 Patients with consciousness disorders mental disorders or communication difficulties unable to complete study questionnaires or scale assessments 5 Local infection inflammation or tumor infiltration at the acupuncture site 6 Coagulation dysfunction (INR > 1.5) or platelet count 7 Use of non-opioid analgesics implantable analgesic pumps nerve blockades or other invasive pain treatments in the past month 8 Patients using non-removable electronic devices or metal implants that may interfere with bioelectrical signal collection 9 Long-term use of immunosuppressants or high-dose corticosteroids
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Minimal Important Difference (MID) in Visual Analogue Scale (VAS) Scores Before and After Treatment; | — |
Secondary
| Measure | Time frame |
|---|---|
| Brief Pain Inventory (BPI);Immediate Analgesic Effect;Electromyography;Karnofsky Performance Status Scale (KPS);Electrooculogram;Long-term Analgesic Effect;Indicator of Changes in Opioid Dosage;Electrodermal Activity;Electroencephalogram; | — |
Countries
china
Contacts
Shenzhen Hospital (Fu Tian) of Guangzhou University of Chinese Medicine